A new study in the Netherlands suggests that transgender women undergoing hormone treatment are at a higher risk for breast cancer compared to cisgender people. Health risks increased during a relatively short duration of the treatment.
Public Health May 17, 2019
Post-menopausal women have greater dementia risk due to the decline in estrogen levels in the brain. A BMJ study concluded that the slight increase in the risk of Alzheimer’s due to oral hormone therapy should not be a cause for alarm.
Neuroscience March 7, 2019
Research found that transgender people who had hormone therapy face greater cardiovascular risk. They are more likely to suffer from stroke, blood clots and heart attacks than cis people. Why?
Public Health February 19, 2019
A study revealed that transgender women receiving hormone therapy are at higher risk of suffering from cardiovascular problems. Does this mean that they should stop taking estrogen to support their transition from male to female?
Medicine July 10, 2018
The TAILORx study showed that the genomic test Oncotype DX can help determine if a breast cancer patient can safely get hormone therapy alone. Who can skip chemotherapy?
Medicine June 3, 2018
The hormone therapy drug abiraterone (Zytiga) can significantly extend the lives of prostate cancer patients by slowing tumor progression and increasing survival rates. These findings came from two clinical trials presented this weekend at the 2017 ASCO Annual Meeting.
Public Health June 7, 2017
Researchers found 79 syndromes linked to genetic causes of obesity, almost triple than previously anticipated. Although rare, these syndromes are much more numerous and diverse than expected and their understanding could help curb obesity rates worldwide.
Public Health March 28, 2017
A roster of five new studies shows that testosterone replacement therapy has resulted in both health benefits and potential risks. Health benefits include anemia, while potential setbacks include more plaque buildup in coronary arteries.
Medicine February 22, 2017
Women who reach menopause by 45 years old were found to have increased risk for heart problems and early death. Hormonal changes possibly contribute to these health problems.
Public Health September 15, 2016
Researchers found that taking hormonal drugs for 10 years, instead of five, may help prevent breast cancer from coming back. The study may pave the way for new and more effective breast cancer therapy in the future.
Healthy Living/Wellness June 5, 2016
Older men who undergo testosterone-suppressing therapy to treat prostate cancer may experience a higher risk of developing clinical depression later in life. This risk seems to increase the longer they stay on the therapy, a new study says.
Life April 12, 2016
The effectiveness of hormone therapy to treat some effects of menopause may depend on whether a woman has had children or not, a study finds. Motherhood changes the way the brain reacts to such therapy, researchers say.
May 26, 2015
Prostate cancer patients undergoing hormone treatments may experience impairment of brain functions, according to a new study. How could this finding help improve outcomes?
Life May 12, 2015
Women who refuse to go on hormone therapy to ease their menopausal symptoms because of risks such as blood clotting and elevated risks for breast cancer may find relief in antidepressants.
Life June 1, 2014
Doctors in Maryland were stunned when they operated on a tumor in the brain of a four month-old baby boy. The tumor has been identified as an adamantinomatous craniopharyngioma, and doctors spotted teeth in the tumor. It is rare for such a mass to contain teeth, although medical researchers have always suspected that both craniopharyngioma and teeth are formed from the same cells.
Life March 2, 2014